Medical-AI trial: AI predicts one-year mortality risk from the ECG — a Software as a Medical Device validated on 462,000 records (NCT07659262)
A study validating a Software as a Medical Device (the Chang Gung ECG Mortality Risk Prediction Software) that analyzes a standard 10-second, 12-lead resting ECG with AI to predict the probability of cardiac-related death within one year, in a multicenter retrospective cohort. Notably, it predicts from the ECG alone without relying on blood tests. The primary outcome is area under the ROC curve (AUC). 461,982 records. Completed.
Trial overview (primary data)
- StatusCompleted
- ConditionsElectrocardiogram, Mortality Risk Prediction
- InterventionsDEVICE: Chang Gung ECG Mortality Risk Prediction Software (Model: CGMH-DRP-001)
- SponsorNational Defense Medical Center, Taiwan
- Target enrollment461,982 participants
- Period2025-04-01 〜 2025-07-21
Key points
- Validates a Software as a Medical Device (SaMD) that analyzes a standard 10-second, 12-lead resting ECG with AI to predict one-year cardiac-related mortality probability.
- Notably predicts from the ECG signal alone, without relying on blood tests (traditional models often lean on labs that may be missing from the EHR).
- Multicenter retrospective cohort; the primary outcome is area under the ROC curve (AUC). Large scale at 461,982 records.
- Could help flag high-risk people even where testing facilities are limited and connect them to work-up or prevention.
- Retrospective performance evaluation; not an assertion of individual prognosis or an establishment of clinical adoption; prediction is a probability.
- The 461,982 records used for validation stand out against the median enrolment of 200 across the 803 trials held as of 2026-09-01.
1What ten seconds of ECG can show
An electrocardiogram (ECG) is a simple, widely available test that records the electrical activity of the heart for about ten seconds. Traditional assessment of mortality or cardiovascular risk has also used values such as blood tests, but these are not always present in the electronic health record and cannot always be computed.
The Software as a Medical Device this study validates avoids that constraint, seeking to estimate the probability of cardiac-related death within one year from the standard ECG waveform alone using AI.
2The software under evaluation
Per the registry summary, the software, the Chang Gung ECG Mortality Risk Prediction Software, is an AI-based Software as a Medical Device (SaMD) that analyzes a standard 10-second, 12-lead resting ECG signal to predict the probability of cardiac-related mortality within one year.
The study validates it in a multicenter retrospective cohort, with the primary outcome being the area under the ROC curve (AUC) for predicting one-year cardiac-related mortality. The scale used for validation is large, at 461,982 records.
3The scale of 460,000 records
The scale used for validation here stands out among the trials this site holds. Placed in the distribution, the size becomes clear.
Risk assessment for death and cardiovascular events has drawn on blood tests, which are not always present in the record. Estimating risk from an ECG alone, obtainable anywhere, would give a handle on identifying high-risk people where testing facilities are thin. A risk prediction remains a probability.
Why it matters
Estimating risk from an ECG that can be taken anywhere, without blood tests, could help flag high-risk people where testing is limited and connect them to work-up or prevention. Large retrospective validation on about 462,000 records is a useful reference for predictive performance near real practice (this study is a retrospective performance evaluation, not clinical adoption or individual prognosis).
FAQ
Can an ECG alone reveal mortality risk?
What is the benefit of not using blood tests?
Sources (primary)
Source: ClinicalTrials.gov (U.S. NIH/NLM, public domain). This site does not provide medical advice. Verify the latest and exact details with the official source. This site is not endorsed or certified by the NIH/NLM.
- ClinicalTrials.gov (study record, original)
- NCT ID: NCT07659262